Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2020-11, Vol.202 (9), p.1304-1308
Main Authors: Zelek, Wioleta M, Cole, Jade, Ponsford, Mark J, Harrison, Richard A, Schroeder, Ben E, Webb, Nicholas, Jolles, Stephen, Fegan, Christopher, Morgan, Matt, Wise, Matt P, Morgan, B Paul
Format: Article
Language:English
Subjects:
Adult
Aged
Betacoronavirus
Complement Inactivator Proteins - administration & dosage
Coronavirus Infections - drug therapy
Coronavirus Infections - epidemiology
Correspondence
COVID-19
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Pandemics
Pneumonia, Viral - drug therapy
Pneumonia, Viral - epidemiology
SARS-CoV-2
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1073-449X
1535-4970
1535-4970
DOI:10.1164/rccm.202007-2778LE